Marvalim C - Search Results

1

Dual p38MAPK and MEK inhibition disrupts adaptive chemoresistance in mesenchymal glioblastoma to temozolomide.

Cheng HS, Chong YK, Lim EKY, Lee XY, Pang QY, Novera W, Marvalim C, Lee JXT, Ang BT, Tang C, Tan NS. Cheng HS, et al. Among authors: marvalim c. Neuro Oncol. 2024 Jul 5;26(7):1247-1261. doi: 10.1093/neuonc/noae028. Neuro Oncol. 2024. PMID: 38366847 Free PMC article.

2

Role of p53 in breast cancer progression: An insight into p53 targeted therapy.

Marvalim C, Datta A, Lee SC. Marvalim C, et al. Theranostics. 2023 Feb 27;13(4):1421-1442. doi: 10.7150/thno.81847. eCollection 2023. Theranostics. 2023. PMID: 36923534 Free PMC article. Review.

3

Kinomic profile in patient-derived glioma cells during hypoxia reveals c-MET-PI3K dependency for adaptation.

Cheng HS, Marvalim C, Zhu P, Law CLD, Low ZYJ, Chong YK, Ang BT, Tang C, Tan NS. Cheng HS, et al. Among authors: marvalim c. Theranostics. 2021 Mar 5;11(11):5127-5142. doi: 10.7150/thno.54741. eCollection 2021. Theranostics. 2021. PMID: 33859738 Free PMC article.

4

The yeast FIT2 homologs are necessary to maintain cellular proteostasis and membrane lipid homeostasis.

Yap WS, Shyu P Jr, Gaspar ML, Jesch SA, Marvalim C, Prinz WA, Henry SA, Thibault G. Yap WS, et al. Among authors: marvalim c. J Cell Sci. 2020 Nov 5;133(21):jcs248526. doi: 10.1242/jcs.248526. J Cell Sci. 2020. PMID: 33033181 Free PMC article.

5

Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence.

Cheng HS, Tan WR, Low ZS, Marvalim C, Lee JYH, Tan NS. Cheng HS, et al. Among authors: marvalim c. Int J Mol Sci. 2019 Oct 11;20(20):5055. doi: 10.3390/ijms20205055. Int J Mol Sci. 2019. PMID: 31614690 Free PMC article. Review.

6

Membrane phospholipid alteration causes chronic ER stress through early degradation of homeostatic ER-resident proteins.

Shyu P Jr, Ng BSH, Ho N, Chaw R, Seah YL, Marvalim C, Thibault G. Shyu P Jr, et al. Among authors: marvalim c. Sci Rep. 2019 Jun 14;9(1):8637. doi: 10.1038/s41598-019-45020-6. Sci Rep. 2019. PMID: 31201345 Free PMC article.

7

Influence of the KDM4A rs586339 polymorphism on overall survival in Asian non-small-cell lung cancer patients.

Marvalim C, Wong JX, Sutiman N, Lim WT, Tan SW, Kanesvaran R, Ng QS, Jain A, Ang MK, Tan WL, Toh CK, Tan EH, Chowbay B. Marvalim C, et al. Pharmacogenet Genomics. 2017 Mar;27(3):120-123. doi: 10.1097/FPC.0000000000000266. Pharmacogenet Genomics. 2017. PMID: 28059867

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7 results

Search Page

Filters